MAIA Biotech raises $1.33M via private placement of common stock and warrants

MAIA Biotechnology, Inc.

Sold 578,643 shares at $2.295/share with warrants to purchase same number at $2.55.
Warrants exercisable 6 months after issuance, 5-year term, no price protection.
Proceeds to fund first third of THIO-101 trial Part C in non-small cell lung cancer.
Closing expected on or about March 28, 2024, subject to customary conditions.
Shares and warrants issued as restricted securities under Rule 144.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MAIA Biotechnology, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $1.33 million (effective 2024-03-25).

Action: entry
Agreement: equity purchase
Counterparty: certain accredited investors
Value: approximately $1.33 million
Effective: 2024-03-25

Exact text from the filing

On March 25, 2024, MAIA Biotechnology, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Investors ”) for the issuance and sale in a private placement (the “ Private Placement ”) of (i) 578,643 shares (the “ Shares ”) of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), and (ii) warrants (the “ Warrants ”) to purchase up to 578,643 shares of Common Stock, at a price per share of $2.295, for an aggregate purchase price of approximately $1.33 million.

View on SEC.gov

536 material agreements filed in the last 30 days. Browse all material agreements →

MAIA Biotechnology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-077564

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.